| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. (DYN) has 7 insiders with recent SEC Form 4 filings, including 4 buys and 2 sells. DYN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 5.28M | $135.43M | - | |
| Dir | 4.10M | $105.22M | - | |
| CEO | 368.2K | $9.45M | - | |
| Other | 169.2K | $4.34M | - | |
| Other | 154.2K | $3.96M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2021 | Scalzo Richard William58 | See Remarks | Sell | 859 | $15.90 | $13,654.99 | -3.8% | -23.9% | -16.3% | |
| Sep 21, 2020 | Vv Manager Ii, LLC | 10% Owner | Buy | 815,000 | $19.00 | $15,485,000.00 | +38.0% | - | - | |
| Sep 21, 2020 | Ra Capital Management, L.P.52 | 10% Owner | Buy | 660,000 | $19.00 | $12,540,000.00 | +30.8% | - | - | |
| Sep 21, 2020 | Logos Global Management LP | 10% Owner | Buy | 700,000 | $19.00 | $13,300,000.00 | +87.0% | - | - |